{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:50:11Z","timestamp":1779281411103,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.anndiagpath.2022.152077","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T12:18:08Z","timestamp":1670933888000},"page":"152077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["From the archives of MD Anderson Cancer Center: Aleukemic T-prolymphocytic leukemia, a rare presentation and review of the literature"],"prefix":"10.1016","volume":"62","author":[{"given":"Karen A.","family":"Nahmod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beenu","family":"Thakral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.N.U.","family":"Aakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swaminathan P.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres E.","family":"Quesada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.anndiagpath.2022.152077_bb0005","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood.V78.12.3269.3269","article-title":"Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia","volume":"78","author":"Matutes","year":"1991","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.152077_bb0010","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1182\/blood-2012-01-380139","article-title":"How I treat T-prolymphocytic leukemia","volume":"120","author":"Dearden","year":"2012","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.anndiagpath.2022.152077_bb0015","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.2019000402","article-title":"Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia","volume":"134","author":"Staber","year":"2019","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.anndiagpath.2022.152077_bb0020","doi-asserted-by":"crossref","first-page":"12530","DOI":"10.1073\/pnas.91.26.12530","article-title":"Identification of the TCL1 gene involved in T-cell malignancies","volume":"91","author":"Virgilio","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.152077_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-4608(91)90228-M","article-title":"Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia","volume":"55","author":"Brito-Babapulle","year":"1991","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.152077_bb0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/gcc.22313","article-title":"Genetic characterization of T-PLL reveals two major biologic subgroups and JAK3 mutations as prognostic marker","volume":"55","author":"Stengel","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.152077_bb0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nri1859","article-title":"The SIRP family of receptors and immune regulation","volume":"6","author":"Barclay","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.152077_bb0040","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13045-021-01197-w","article-title":"Targeting CD47 for cancer immunotherapy","volume":"14","author":"Jiang","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2022.152077_bb0045","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1365-2141.1998.00977.x","article-title":"Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Fran\u00e7ais d'H\u00e9matologie cellulaire","volume":"103","author":"Garand","year":"1998","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.152077_bb0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ajh.10221","article-title":"Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?","volume":"71","author":"Soma","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.anndiagpath.2022.152077_bb0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2141.1996.457995.x","article-title":"T-cell form of chronic lymphocytic leukaemia: reaffirmation of its existence","volume":"93","author":"Wong","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anndiagpath.2022.152077_bb0060","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1046\/j.1365-2141.1999.01485.x","article-title":"Indolent course as presentation in T-prolymphocytic leukaemia","volume":"105","author":"Domingo-Domenech","year":"1999","journal-title":"Br J Haematol"},{"issue":"suppl_1","key":"10.1016\/j.anndiagpath.2022.152077_bb0065","doi-asserted-by":"crossref","first-page":"A107","DOI":"10.1093\/ajcp\/142.suppl1.107","article-title":"T-Prolymphocytic Leukemia Presenting as Lymphadenopathy and no Lymphocytosis","volume":"142","author":"Al-Saleem","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2022.152077_bb0070","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3109\/10428194.2015.1076932","article-title":"Survival trends in T cell prolymphocytic leukemia: a SEER database analysis","volume":"57","author":"Chandran","year":"2016","journal-title":"Leukemia Lymphoma."},{"issue":"2","key":"10.1016\/j.anndiagpath.2022.152077_bb0075","article-title":"T-cell prolymphocytic leukemia: an overview of current and future approaches","volume":"13","author":"Colon Ramos","year":"2021","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.152077_bb0080","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/PPO.0000000000000412","article-title":"Bruton tyrosine kinase inhibitors: present and future","volume":"25","author":"Burger","year":"2019","journal-title":"Cancer J"},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.152077_bb0085","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.3324\/haematol.2015.135418","article-title":"Activity of the Janus kinase inhibitor ruxolitinib in chronic lymphocytic leukemia: results of a phase II trial","volume":"101","author":"Spaner","year":"2016","journal-title":"Haematologica"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913422001794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913422001794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:35:13Z","timestamp":1761078913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913422001794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":17,"alternative-id":["S1092913422001794"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152077","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From the archives of MD Anderson Cancer Center: Aleukemic T-prolymphocytic leukemia, a rare presentation and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152077"}}